Labshake search
Citations for Stemcell Technologies :
251 - 300 of 980 citations for Recombinant Human ITCH None tagged since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2020Quote: Human cord blood or mobilized peripheral blood CD34+ HSCs (StemCell Technologies) were differentiated into enucleated RBCs using a modified version of a previously-described protocol11 ...
-
bioRxiv - Bioengineering 2021Quote: Human peripheral blood cells (PBMCs) were purchased from STEMCELL Technologies (#70025). 100M PBMCs were thawed in 100 mL X-VIVO™ 10 media from Lonza (#04-380Q ...
-
bioRxiv - Immunology 2020Quote: Human peripheral blood mononuclear cells were purchased from Stemcell Technologies (#70025) and CD8+ T cells isolated using the EasySep Human CD8+ T Cell Isolation kit (Stemcell Technologies ...
-
bioRxiv - Physiology 2020Quote: ... enteroids were maintained in Human IntestiCult components A+B (STEMCELL Technologies). To promote differentiation ...
-
bioRxiv - Immunology 2022Quote: ... and human BAFF46 in 80 mL StemCell medium A (StemCell Technologies) containing 6.3 μg/mL of CpG (phosphorothioate-modified oligodeoxynucleotide ZOEZOEZZZZZOEEZOEZZZT ...
-
bioRxiv - Microbiology 2020Quote: ... Human bone marrow CD34+ HPCs were obtained from Stem cell Technologies and recovered in SFEMII (Stem Cell Technologies ...
-
bioRxiv - Immunology 2022Quote: CD34+ cells were isolated from human cord blood (Stemcell Technologies #17896) and cultured for 2 days in expansion media (Miltenyi #130-100-473) ...
-
bioRxiv - Molecular Biology 2021Quote: Human PBMCs were isolated from healthy peripheral whole blood (STEMCELL Technologies) by using gradient method with the Ficoll-Paque (GE Healthcare) ...
-
bioRxiv - Cancer Biology 2021Quote: ... EasySep™ Human Epcam positive selection kit (Stemcell Technologies, Cat# 17846) was used on the single cell suspension for Epcam positive OC epithelial cell selection following manufacturer instructions.
-
Loss of TREM2 reduces hyperactivation of progranulin deficient microglia but not lysosomal pathologybioRxiv - Neuroscience 2021Quote: ... in combination with RosetteSep Human Monocyte Enrichment Cocktail (StemCell Technologies, #15068) according to the manufacturer’s protocol ...
-
bioRxiv - Immunology 2020Quote: ... and human BAFF52 in 80 mL StemCell medium A (StemCell Technologies) containing 6.3 μg/mL of CpG (phosphorothioate-modified oligodeoxynucleotide ZOEZOEZZZZZOEEZOEZZZT ...
-
bioRxiv - Immunology 2020Quote: ... and Easysep release human biotin positive selection cocktail (17653, STEMCELL Technologies). CD19+CD11c+ B cells (ABCs ...
-
bioRxiv - Genetics 2019Quote: Human iPSCs were cultured on vitronectin-XF-coated plates (Stemcell Technologies) and TeSR-E8 medium (Stemcell Technologies) ...
-
bioRxiv - Genomics 2021Quote: Human peripheral blood mononuclear cells were purchased from Stemcell Technologies (#70025) and T cells isolated using the EasySep Human T Cell Isolation kit (Stemcell Technologies ...
-
bioRxiv - Cancer Biology 2022Quote: Cryopreserved human cord blood-derived CD34+ cells (STEMCELL Technologies, Cambridge, MA) were rapidly thawed at 37°C ...
-
bioRxiv - Immunology 2022Quote: For monocyte/macrophage monocultures cryopreserved primary human CD14+ monocytes (Stemcell Technologies) isolated from peripheral blood were plated at 300,000 cells/well in flat bottom ...
-
NSC-derived exosomes enhance therapeutic effects of NSC transplantation on cerebral ischemia in micebioRxiv - Neuroscience 2022Quote: ... Human iPSCs were cultured with STEMdiff Neural Induction Medium (Stemcell Technologies). The medium was replaced daily until day 9 ...
-
bioRxiv - Molecular Biology 2023Quote: Human Peripheral Blood Mononuclear Cells (PBMCs) were purchased from StemCell Technology. Samples from three individual donors were thawed at 37°C for 3 minutes and then diluted into 5 mL of FACS buffer (0.5% BSA in 1x PBS) ...
-
bioRxiv - Neuroscience 2023Quote: ... Human iPSC cells were cultured in mTeSR Plus (Stem Cell Technology) on 5 µg/ml BioLaminin 521LN (Biolamina ...
-
bioRxiv - Cancer Biology 2022Quote: ... and human EGF (20 ng/ml, Stem Cell Technologies, cat# 78006). HMC3 human microglia cell line is cultured in Eagle’s Minimum Essential Medium (EMEM ...
-
bioRxiv - Cancer Biology 2024Quote: ... and EasySep Human CD8 T Cell Iso Kit (Stemcell Technologies, 17953). CD3+ T-cells were thawed ...
-
bioRxiv - Cancer Biology 2024Quote: ... and EasySep Human CD4 T Cell Iso Kit (Stemcell Technologies, 17952) and EasySep Human CD8 T Cell Iso Kit (Stemcell Technologies ...
-
bioRxiv - Developmental Biology 2024Quote: Primed H9 human ESC were cultured according in mTeSR1 (StemCell Technologies) according to the manufacturer’s guidance ...
-
bioRxiv - Biophysics 2023Quote: ... Direct Human T cells isolation kits (EasySep™, STEMCELL Technologies, USA) were used according to the manufacturer’s instructions.
-
bioRxiv - Bioengineering 2023Quote: Human peripheral blood CD8+ T cells (Stem Cell Technologies, 200-0164) were cultured in ImmunoCult XF T Cell Expansion media (Stem Cell Technologies ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 10% NeuroCult™ Proliferation Supplement (Human) (STEMCELL Technologies, 05753), heparin solution (final concentration ...
-
bioRxiv - Bioengineering 2023Quote: Human peripheral blood CD4+ T cells (Stem Cell Technologies, 200-0165) were cultured in ImmunoCult-XF T Cell Expansion media (Stem Cell Technologies ...
-
bioRxiv - Cell Biology 2023Quote: ... human iPSCs were passaged with Accutase (Stem Cell Technologies, Vancouver, Canada) and re-plated at a density of 1 to 2×105 per cm2 in growth factor reduced Matrigel (Corning Incorporated ...
-
bioRxiv - Developmental Biology 2023Quote: ... supplemented with 10 ng/ml human FGF2 (Stem Cell Technologies 78003). Individual iPSC colonies were mechanically picked ...
-
Chimeric Antigen Cytotoxic Receptors for In-Vivo Engineering of Tumor-targeting Natural Killer CellsbioRxiv - Immunology 2023Quote: ... ImmunoCult™ human CD3/CD28/CD2 T-cell activator (StemCell Technologies) was used to activate isolated T cells in vitro for 2 days following the manufacturer’s recommendations.
-
bioRxiv - Cancer Biology 2023Quote: ... using EasySepTM Human CD4+ T Cell Isolation Kit (StemCell Technologies, 17952), and human CD11b+ cells (described above ...
-
bioRxiv - Cancer Biology 2024Quote: ... 20 ng/ml human basic fibroblast growth factor (Stemcell Technologies, 78003), 2 μg/ml heparin (Stemcell Technologies ...
-
bioRxiv - Cancer Biology 2023Quote: ... which consisted of NS-A Basal Medium (Human) (STEMCELL Technologies, 05750) supplemented with 10% NeuroCult™ Proliferation Supplement (Human ...
-
bioRxiv - Microbiology 2024Quote: ... the Easy Human Pan-B Cell Enrichment kit (STEMCELL Technologies #19554) was used ...
-
bioRxiv - Bioengineering 2024Quote: ... or ReLeSRTM human PSC selection and passaging reagent (Stemcell Technologies; 05872). The differentiation of iPSCs into foregut cells was performed using previously published protocols13,21 ...
-
bioRxiv - Bioengineering 2024Quote: ... and 6 × 103 human bone marrow CD34+ cells (STEMCELL Technologies, 70002.3) into a collagen-based hydrogel according to the protocol described previously (49 ...
-
bioRxiv - Neuroscience 2024Quote: ... with 10% human platelet-derived lysate (Stem Cell Technologies, Cat#06960) and 1% Penicillin-Streptomycin solution (Pen-Strep ...
-
bioRxiv - Cancer Biology 2024Quote: The RosetteSep™ Human CD45 Depletion Cocktail (Catalog #15112, StemCell Technologies) was used in this study to enrich cancer cells spiked into whole blood ...
-
bioRxiv - Immunology 2024Quote: ... Peripheral blood mononuclear cells from healthy donors were purified from leukopaks purchased from Stem Cell Technologies using Ficoll EasySep Direct Human PBMC Isolation Kits (Stem Cell Technologies) as per the manufacturer’s instructions ...
-
bioRxiv - Immunology 2024Quote: Female CatchupIVM-red and FVB/N mice aged 8-15 weeks were treated with 5 µg mouse recombinant G-CSF (STEMCELL Technologies) by intraperitoneal injection (i.p. ...
-
bioRxiv - Cancer Biology 2022Quote: ... BT179 and BT333 were maintained in NeuroCult proliferation medium (human) (StemCell Technologies) with 20 ng/ml EGF ...
-
bioRxiv - Molecular Biology 2021Quote: ... were suspended in Intesticult (INT) human organoid growth medium (Stem Cell Technologies) proliferation medium ...
-
bioRxiv - Neuroscience 2019Quote: ... ImmunoCult Human CD3/CD28 T cell Activator and 20ng rhIL2 (Stemcell Technologies) was added to culture medium ...
-
bioRxiv - Neuroscience 2019Quote: ... anti-human CD40 antibody (clone 5C3) and 20 ng rhIL4 (Stemcell Technologies) was added to culture medium ...
-
bioRxiv - Immunology 2021Quote: PBMCs were isolated from six human peripheral blood leukapheresis packs (STEMCELL Technologies) using Ficoll gradient density centrifugation ...
-
bioRxiv - Bioengineering 2021Quote: ... human iPSCs were cultured in mTeSR+ stem cell medium (Stem Cell Technologies) on Matrigel coated plates (Corning ...
-
bioRxiv - Bioengineering 2021Quote: ... the EasySep™ Human PE Positive Selection Kit II (STEMCELL Technologies, 17664), and EasySep™ Magnet (STEMCELL Technologies ...
-
bioRxiv - Bioengineering 2021Quote: ... the EasySep™ Human PE Positive Selection Kit II (STEMCELL Technologies, 17664), and EasySep™ Magnet (STEMCELL Technologies ...
-
bioRxiv - Immunology 2021Quote: ... or T cells (EasySep Human T cell Isolation Kit, Stemcell Technologies, #17951). After isolation ...
-
bioRxiv - Cancer Biology 2022Quote: ... and CD66b+ cells (RosetteSep Human CD45 Depletion Cocktail, STEMCELL Technologies Inc., Canada). Blood samples were incubated with RosetteSep Cocktail (50 μl per 1 ml blood ...